132 related articles for article (PubMed ID: 10940491)
1. Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway.
Kanter-Lewensohn L; Girnita L; Girnita A; Dricu A; Olsson G; Leech L; Nilsson G; Hilding A; Wejde J; Brismar K; Larsson O
Mol Cell Endocrinol; 2000 Jul; 165(1-2):131-7. PubMed ID: 10940491
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y
Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
Periyasamy-Thandavan S; Takhar S; Singer A; Dohn MR; Jackson WH; Welborn AE; LeRoith D; Marrero M; Thangaraju M; Huang S; Schoenlein PV
Breast Cancer Res; 2012 Mar; 14(2):R52. PubMed ID: 22429491
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
7. [Effects of electroacupuncture at "Zhongliao" (BL 33) and "Tianshu" (ST 25) on ovarian function in rats with premature ovarian insufficiency].
Wang W; Wang Y; Wu J; Yang L; Liu Z
Zhongguo Zhen Jiu; 2018 May; 38(5):5193-26. PubMed ID: 29797918
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
9. Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
Dricu A; Kanter L; Wang M; Nilsson G; Hjertman M; Wejde J; Larsson O
Glycobiology; 1999 Jun; 9(6):571-9. PubMed ID: 10336989
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Mol Cell Endocrinol; 2000 Jul; 165(1-2):173-8. PubMed ID: 10940495
[TBL] [Abstract][Full Text] [Related]
11. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Kanter-Lewensohn L; Dricu A; Wang M; Wejde J; Kiessling R; Larsson O
Melanoma Res; 1998 Oct; 8(5):389-97. PubMed ID: 9835451
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
[TBL] [Abstract][Full Text] [Related]
14. Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.
Toms SA; Hercbergs A; Liu J; Kondo S; Haqqi T; Casey G; Iwasaki K; Barnett GH; Barna BP
J Neurosurg; 1998 May; 88(5):884-9. PubMed ID: 9576258
[TBL] [Abstract][Full Text] [Related]
15. Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.
Santen RJ; Fan P; Zhang Z; Bao Y; Song RX; Yue W
Steroids; 2009 Jul; 74(7):586-94. PubMed ID: 19138696
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
Vaziri-Gohar A; Zheng Y; Houston KD
Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
[TBL] [Abstract][Full Text] [Related]
17. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID
J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544
[TBL] [Abstract][Full Text] [Related]
18. Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R).
Li Q; You C; Liu L; Rao Z; Sima X; Zhou L; Xu J
J Clin Neurosci; 2013 Jan; 20(1):153-7. PubMed ID: 23117141
[TBL] [Abstract][Full Text] [Related]
19. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]